-
EP3318124
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3318124
| EP3318124 - PHARMACOKINETIC ANIMAL MODEL [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.05.2019 Database last updated on 12.07.2024 | |
| Former | The application has been published Status updated on 06.04.2018 | Most recent event Tooltip | 24.05.2019 | Application deemed to be withdrawn | published on 26.06.2019 [2019/26] | Applicant(s) | For all designated states Albumedix Ltd Castle Court, 59 Castle Boulevard Nottingham NG7 1FD / GB | [2018/31] |
| Former [2018/19] | For all designated states Albumedix A/S Lottenborgvej 26 2800 Kgs. Lyngby / DK | Inventor(s) | 01 /
CAMERON, Jason 24 Lees Road Mapperley Nottingham NG3 6HB / GB | 02 /
SLEEP, Darrell 66 Ladybay Road West Bridgford Nottingham NG2 5DS / GB | 03 /
SANDLIE, Inger Roaveien 16A 0752 Oslo / NO | 04 /
ANDERSEN, Jan Terje Hallagerbakken 66F 1256 Oslo / NO | [2018/19] | Representative(s) | Williams, Rachel Clare Sartorius Albumedix Limited Mabel Street Nottingham NG2 3ED / GB | [N/P] |
| Former [2018/19] | Williams, Rachel Clare Albumedix Ltd Castle Court 59 Castle Boulevard Nottingham NG7 1FD / GB | Application number, filing date | 17186961.3 | 14.02.2014 | [2018/19] | Priority number, date | EP20130155554 | 16.02.2013 Original published format: EP 13155554 | EP20130180587 | 15.08.2013 Original published format: EP 13180587 | [2018/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3318124 | Date: | 09.05.2018 | Language: | EN | [2018/19] | Type: | A3 Search report | No.: | EP3318124 | Date: | 30.05.2018 | Language: | EN | [2018/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.05.2018 | Classification | IPC: | A01K67/00, G01N33/68 | [2018/22] | CPC: |
A01K67/0278 (EP,US);
G01N33/68 (US);
A01K67/0275 (US);
C07K14/70535 (EP,US);
C07K14/765 (EP,US);
A01K2217/052 (US);
A01K2217/072 (EP,US);
A01K2217/075 (EP,US);
A01K2227/105 (EP,US);
A01K2227/107 (EP,US);
A01K2227/108 (EP,US);
A01K2267/02 (EP,US);
|
| Former IPC [2018/19] | A01K67/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/19] | Title | German: | PHARMAKOKINETISCHES TIERMODELL | [2018/19] | English: | PHARMACOKINETIC ANIMAL MODEL | [2018/19] | French: | MODÈLE PHARMACOCINÉTIQUE ANIMAL | [2018/19] | Examination procedure | 01.12.2018 | Application deemed to be withdrawn, date of legal effect [2019/26] | 30.01.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2019/26] | Parent application(s) Tooltip | EP14705493.6 / EP2956002 | Fees paid | Renewal fee | 18.12.2017 | Renewal fee patent year 03 | 18.12.2017 | Renewal fee patent year 04 | 28.02.2018 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 28.02.2019 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]EP0438102 (BREM GOTTFRIED PROF DR DR MED [DE]) [Y] 1-5,7-15 * claim 1 *; | [XD]WO2011051489 (NOVOZYMES BIOPHARMA DK AS [DK], et al) [XD] 11 * claims 2-8 *; | [XDY]WO2011103076 (MEDIMMUNE LLC [US], et al) [XD] 11 * paragraph [0502] - paragraph [0511] * [Y] 1-5,7-15; | [X] - S. HALLSTROM ET AL, "S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia", CARDIOVASCULAR RESEARCH, (20080201), vol. 77, no. 3, doi:10.1093/cvr/cvm052, ISSN 0008-6363, pages 506 - 514, XP055109488 [X] 1-6,8-15 * table 1 * DOI: http://dx.doi.org/10.1093/cvr/cvm052 | [XA] - Lizzie Allan ET AL, "Enhanced albumins and albumin fusion technology: tuning circulatory half-life with Novozymes Albufuse Flex to meet medical needs", (20120504), URL: http://www.biopharma.novozymes.com/en/information-centre/posters-and-presentations/Documents/PEGS%20poster%202012_EZAL.pdf, (20140324), XP055109701 [X] 11 * table 4 * [A] 1-6,8-10,12-15 | [A] - IMRE KACSKOVICS ET AL, "Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies", MABS, (20110901), vol. 3, no. 5, doi:10.4161/mabs.3.5.17023, ISSN 1942-0862, pages 431 - 439, XP055120647 [A] 1-5,7-15 * abstract * DOI: http://dx.doi.org/10.4161/mabs.3.5.17023 | by applicant | WO9109125 | WO0069902 | WO0071079 | WO0179271 | WO0179258 | WO0179442 | WO0179443 | WO0179480 | WO03059934 | WO03060071 | WO03066824 | WO2004071536 | WO2005003296 | US6949691 | WO2007021494 | WO2007090584 | WO2007144173 | WO2008007146 | US7358416 | WO2009019314 | WO2009058322 | WO2010065950 | WO2010092135 | WO2011051489 | WO2011103076 | WO2011124718 | WO2012059486 | WO2012112188 | WO2012150319 | WO2013135896 | - KRAGH-HANSEN et al., Biol. Pharm. Bull., (20020000), vol. 25, page 695 | - KURTZHALS et al., J. Pharm. Sci., (19970000), vol. 86, page 1365 | - KRATZ, J. Controlled Release, (20080000), vol. 132, pages 171 - 183 | - OTAGIRI et al., Biol. Pharm. Bull., (20090000), vol. 32, no. 4, pages 527 - 534 | - ANDERSEN et al., Clinical Biochemistry, (20100000), vol. 43, pages 367 - 372 | - GALLIANO et al., Biochim. Biophys. Acta, (19930000), vol. 1225, pages 27 - 32 | - MINCHIOTTI et al., Biochim. Biophys. Acta, (19870000), vol. 916, pages 411 - 418 | - TAKAHASHI et al., Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, pages 4413 - 4417 | - CARLSON et al., Proc. Nat. Acad. Sci. USA, (19920000), vol. 89, pages 8225 - 8229 | - PEACH, R. J.; BRENNAN, S. 0., Biochim Biophys Acta, (19910000), vol. 1097, pages 49 - 54 | - IWAO, B.B.A. Proteins and Proteomics, (20070000), vol. 1774, pages 1582 - 1590 | - MAHMOOD I, New Drug Development, Regulatory Paradigms for Clinical Pharmacology and Biopharmaceutics, Informa Healthcare, (20040000), pages 137 - 163 | - HALL C. et al., J. Pharma Sci., (20120000), vol. 101, pages 1221 - 1241 | - LARSEN M. O.; ROLIN B., ILAR Journal, (20040000), vol. 45, pages 303 - 313 | - ZHENG Y. et al., mAbs, (20120000), vol. 4, pages 243 - 255 | - SUENDERHAUF C.; PARROTT N., Pharm. Res., (20130000), vol. 30, pages 1 - 15 | - ROOPENIAN et al., J. Immunol., (20030000), vol. 170, pages 3528 - 3533 | - ANDERSEN J.T., J Biol. Chem. 12, (20100000), vol. 285, no. 7, pages 4826 - 4836 | - "Serum albumin", UniProt, Database accession no. P07724 | - "IgG receptor FcRn large subunit p51", UniProt, Database accession no. Q61559 | - "Beta-2-microglobulin", UniProt, Database accession no. Q91Z73 | - NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 443 - 453 | - RICE et al., "EMBOSS: The European Molecular Biology Open Software Suite", Trends Genet, (20000000), vol. 16, doi:doi:10.1016/S0168-9525(00)02024-2, pages 276 - 277, XP004200114 DOI: http://dx.doi.org/10.1016/S0168-9525(00)02024-2 | - HOEFS, J.C., Hepatology, (19920000), vol. 16, pages 396 - 403 | - PETERS, T., JR., All about Albumin: Biochemistry, Genetics and Medical, Applications, Academic Press, Inc., (19960000), page 10 | - C.L. ANDERSON et al., Trends in Immuno., (20060000), vol. 27, pages 343 - 348 | - J. KIMET, Clinical Immuno., (20070000), vol. 122, pages 146 - 155 | - GHINEA A. et al., J. Cell Biol., (19880000), vol. 107, pages 231 - 239 | - SCHNITZER J et al., J. Biol. Chem., (19920000), vol. 267, pages 24544 - 24553 | - SCHNITZER J. et al., J. Biol. Chem., (19930000), vol. 268, pages 7562 - 7570 | - SCHNITZER et al., J. Biol. Chem., (19940000), vol. 269, pages 6072 - 6082 | - MINSHALL R., Histochem. Cell. Biol., (20020000), vol. 117, pages 105 - 112 | - MALIK A. B., J. Med. Sci., (20090000), vol. 2, pages 13 - 17 | - PREDESCU D.; PALADE G. E., Am. J. Physiol., (19930000), vol. 265, pages H725 - H733 | - ANDERSON C. L. et al., Trends in Immuno., (20060000), vol. 7, pages 343 - 348 | - ROOPENIAN D. C.; AKILESH, S., Nat. Rev. Immunol, (20070000), vol. 7, pages 715 - 725 | - BAKER K., Semin Immunopathol., (20090000), vol. 31, pages 223 - 236 | - ANDERSEN J. T.; SANDLIE I., Drug Metab. Pharmacokinet, (20090000), vol. 24, pages 318 - 332 | - KUO T. T. et al., J. Clin. Immunol, (20100000), vol. 30, pages 777 - 789 | - GEKLE M., Ann. Rev. Physiol., (20050000), vol. 67, pages 573 - 594 | - NAKAJOU et al., Biochim Biophys Acta, (20030000), vol. 1623, pages 88 - 97 | - IWAO Y. et al., Biochim Biophys Acta, (20060000), vol. 1764, pages 743 - 749 | - LWAO Y et al., Biochim Biophys Acta, (20070000), vol. 1774, pages 1582 - 1590 | - SHEFFIELD W. P. et al., Thrombosis Research, (20000000), vol. 99, pages 613 - 621 | - IWAO Y. et al., Biochim Biophys Acta, (20090000), vol. 1794, pages 634 - 641 | - ANDERSEN J. T. et al., Clin Biochem., (20100000), vol. 43, pages 367 - 372 | - BEEKEN et al., J. Clin. Invest, (19620000), vol. 62, page 1312 | - ANDERSEN et al., Nat. Commun., (20100000), vol. 3, page 610 | - ANDERSEN et al., Nature Communications, (20120000), vol. 3, page 610 | - ANDERSEN et al., Eur. J. Immunol, (20060000), vol. 36, pages 3044 - 3051 | - CHAUDHURY et al., Biochemistry, (20060000), vol. 45, pages 4983 - 4990 | - ANDERSEN J. T.; SANDLIE I., Drug Metab. Pharmacokinet., (20090000), vol. 24, pages 318 - 332 | - OBER et al., Int. Immunol, (20010000), vol. 13, pages 1551 - 1559 | - ANDERSEN et al., Journal of Biological Chemistry, (20100000), vol. 285, pages 4826 - 4836 | - MULLER et al., Journal of Biological Chemistry, (20070000), vol. 282, pages 12650 - 12660 | - OBER R. J. et al., Int. Immunol., (20010000), vol. 13, pages 1551 - 1559 | - STEIN C. et al., Mamm. Genome, (20110000), vol. 23, pages 259 - 269 | - MULLER et al., Journal of Biological Chemistry, (20070000), vol. 282, page 12650 | - ANDERSON et al., Nature Communication, (20120000), vol. 3, page 610 | - ANDERSEN et al., Eur. J. Immonol., (20060000), vol. 36, pages 3044 - 3051 | - MARTIN et al., J. Ind. Microbiol. Biotechnol., (20030000), vol. 3, pages 568 - 576 | - SVETINA et al., J. Biotechnol., (20000000), vol. 76, pages 245 - 251 | - RASMUSSEN-WILSON et al., Appl. Environ. Microbiol., (19970000), vol. 63, pages 3488 - 3493 | - WARD et al., Biotechnology, (19950000), vol. 13, pages 498 - 503 | - CONTRERAS et al., Biotechnology, (19910000), vol. 9, pages 378 - 381 | - EATON et al., Biochemistry, (19860000), vol. 25, pages 505 - 512 | - COLLINS-RACIE et al., Biotechnology, (19950000), vol. 13, pages 982 - 987 | - CARTER et al., Proteins: Structure, Function, and Genetics, (19890000), vol. 6, pages 240 - 248 | - STEVENS, Drug Discovery World, (20030000), vol. 4, pages 35 - 48 | - Pharmaceutical Research, (19930000), vol. 10, no. 9, pages 1387 - 1388 | - KURTZHALS P et al., Biochem. J., (19950000), vol. 312, pages 725 - 731 | - ANDERSEN et al., FEBS J, (20080000), vol. 275, no. 16, pages 4097 - 4110 | - ANDERSEN et al., J Biol. Chem. 12, (20100000), vol. 285, no. 7, pages 4826 - 4836 | - ANDERSEN et al., J. Biol. Chem, (20110000), vol. 286, pages 5234 - 5241 | - BERNTZEN et al., J Immunol Methods, (20050000), vol. 298, pages 93 - 104 | - KARLSSON et al., J. Immunol. Methods, (19970000), vol. 200, pages 121 - 133 | - ORR-WEAVER; SZOSTAK, Proc. Natl. Acad. Sci. USA., (19830000), vol. 80, pages 4417 - 4421 | - PAYNE et al., Applied and Environmental Microbiology, (20080000), vol. 74, no. 24, pages 7759 - 7766 | - EVANS et al., Protein Expression and Purification, (20100000), vol. 73, no. 2, pages 113 - 124 | WO2013EP73426 |